Synergistic Effect of Colistin Combined with PFK-158 against Colistin-Resistant Enterobacteriaceae

As increasing numbers of colistin-resistant bacteria emerge, new therapies are urgently needed to treat infections caused by these pathogens. The discovery of new combination therapies is one important way to solve such problems. Here, we report that the antitumor drug PFK-158 and its analogs PFK-01...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: Zhang, Youwen, Wang, Xiukun, Li, Xue, Dong, Limin, Hu, Xinxin, Nie, Tongying, Lu, Yun, Lu, Xi, Pang, Jing, Li, Guoqing, Yang, Xinyi, Li, Congran, You, Xuefu
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2019
Onderwerpen:
Experimental Therapeutics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6591609/
https://ncbi.nlm.nih.gov/pubmed/30988150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00271-19
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items